Physicians' perceptions of the definition of major bleeding in major orthopedic surgery: Results of an international survey

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 2, 2011, Pages 188-195

  Ginzburg, Enrique ^b   Dujardin, Franck ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Major bleeding; Orthopedic surgery; Survey; Thromboprophylaxis

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; BLEEDING; DRUG SAFETY; FATALITY; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; MAJOR SURGERY; ORTHOPEDIC SURGERY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RANDOMIZATION; REHABILITATION CARE; REOPERATION; RISK BENEFIT ANALYSIS; RISK REDUCTION; SURGEON; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EUROPE; HEMORRHAGE; ORTHOPEDIC PROCEDURES; PHYSICIANS; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; RISK FACTORS; THROMBOEMBOLISM; UNITED STATES;

EID: 79951726723     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0498-9     Document Type: Article

References (20)

1. WH Geerts D Bergqvist GF Pineo JA Heit CM Samama MR Lassen CW Colwell American College of Chest Physicians 2008 Prevention of venous thromboembolism: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edn) Chest 133 Suppl. 6 381S 453S 1:CAS:528:DC%2BD1cXptVKh (Pubitemid 351894916)
2. BI Eriksson LC Borris RJ Friedman S Haas MV Huisman AK Kakkar TJ Bandel H Beckmann E Muehlhofer F Misselwitz W Geerts RECORD1 Study Group 2008 Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty N Engl J Med 358 2765 2775 1:CAS:528:DC%2BD1cXnvFahtbo%3D 10.1056/NEJMoa0800374 18579811 (Pubitemid 351930851)
3. AK Kakkar B Brenner OE Dahl BI Eriksson P Mouret J Muntz AG Soglian AF Pap F Misselwitz S Haas RECORD2 Investigators 2008 Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial Lancet 372 31 39 1:CAS:528:DC%2BD1cXotlWqsrg%3D 10.1016/S0140-6736(08)60880-6 18582928
4. MR Lassen W Ageno LC Borris JR Lieberman N Rosencher TJ Bandel F Misselwitz AG Turpie RECORD3 Investigators 2008 Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty N Engl J Med 358 2776 2786 1:CAS:528:DC%2BD1cXnvFagt70%3D 10.1056/NEJMoa076016 18579812 (Pubitemid 351930852)
5. AG Turpie MR Lassen BL Davidson KA Bauer M Gent LM Kwong FD Cushner PA Lotke SD Berkowitz TJ Bandel A Benson F Misselwitz WD Fisher RECORD4 Investigators 2009 Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Lancet 373 1673 1680 1:CAS:528:DC%2BD1MXmtVWjtL4%3D 10.1016/S0140-6736(09)60734-0 19411100
6. BI Eriksson OE Dahl N Rosencher AA Kurth CN van Dijk SP Frostick P Kälebo AV Christiansen S Hantel R Hettiarachchi J Schnee RE-MODEL Büller HR Study Group 2007 Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial J Thromb Haemost 5 2178 2185 1:CAS:528:DC%2BD2sXhsVSis7fM 10.1111/j.1538-7836.2007.02748.x 17764540 (Pubitemid 47617868)
7. BI Eriksson OE Dahl N Rosencher AA Kurth CN van Dijk SP Frostick MH Prins R Hettiarachchi S Hantel J Schnee Büller HR RE-NOVATE Study Group 2007 Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial Lancet 370 949 956 1:CAS:528:DC%2BD2sXhtVeqsL7F 10.1016/S0140-6736(07)61445-7 17869635 (Pubitemid 47393577)
8. RE-MOBILIZE Writing Committee JS Ginsberg BL Davidson PC Comp CW Francis RJ Friedman MH Huo JR Lieberman JE Muntz GE Raskob ML Clements S Hantel JM Schnee JA Caprini 2009 Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery J Arthroplasty 24 1 9 18534438
9. MR Lassen GE Raskob A Gallus G Pineo D Chen RJ Portman 2009 Apixaban or enoxaparin for thromboprophylaxis after knee replacement N Engl J Med 361 594 604 1:CAS:528:DC%2BD1MXps1Kitrc%3D 10.1056/NEJMoa0810773 19657123
10. HG Eichler E Abadie JM Raine T Salmonson 2009 Safe drugs and the cost of good intentions N Engl J Med 360 1378 1380 1:CAS:528:DC%2BD1MXjvFCrtLw%3D 10.1056/NEJMp0900092 19339718
11. RD Hull RD Yusen D Bergqvist 2009 State-of-the-art review: assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxis Clin Appl Thromb Hemost 15 377 388 1:CAS:528: DC%2BD1MXhtValu7vK 10.1177/1076029609338712 19608549
12. S Schulman RJ Beyth C Kearon MN Levine American College of Chest Physicians 2008 Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn) Chest 133 6 Suppl 257S 298S 1:CAS:528:DC%2BD1cXptVKhsr4%3D 10.1378/chest.08-0674 18574268 (Pubitemid 351892969)
13. I Pitrou I Boutron N Ahmad P Ravaud 2009 Reporting of safety results in published reports of randomized controlled trials Arch Intern Med 169 1756 1761 10.1001/archinternmed.2009.306 19858432
14. JP Ioannidis 2009 Adverse events in randomized trials: neglected, restricted, distorted, and silenced Arch Intern Med 169 1737 1739 10.1001/archinternmed.2009.313 19858427
15. S Schulman U Angerås D Bergqvist B Eriksson MR Lassen W Fisher Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis 2010 Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients J Thromb Haemost 8 202 204 1:STN:280:DC%2BC3c7ksFChtA%3D%3D 10.1111/j.1538-7836.2009.03678.x 19878532
16. M Montserrat Vera-Llonch M Hagiwara G Oster 2006 Clinical and economic consequences of bleeding following major orthopedic surgery Thromb Res 117 569 577 10.1016/j.thromres.2005.04.018 15913715 (Pubitemid 43326144)
17. RG Holzheimer 2004 Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH) Eur J Med Res 9 150 170 1:CAS:528:DC%2BD2cXkslynsro%3D 15096326
18. P Casais SS Meschengieser A Sanchez-Luceros MA Lazzari 2005 Patients' perceptions regarding oral anticoagulation therapy and its effect on quality of life Curr Med Res Opin 21 1085 1090 1:STN:280:DC%2BD2Mzlt1KgsA%3D%3D 10.1185/030079905X50624 16004677 (Pubitemid 41032699)
19. G Cullen E Kelly FE Murray 2006 Patients' knowledge of adverse reactions to current medications Br J Clin Pharmacol 62 232 236 10.1111/j.1365-2125.2006. 02642.x 16842399 (Pubitemid 44316433)
20. MH Prins I Guillemin H Gilet S Gabriel B Essers G Raskob SR Kahn 2009 Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q) Health Qual Life Outcomes 7 30 1:STN:280: DC%2BD1MznsF2juw%3D%3D 10.1186/1477-7525-7-30 19348685